Matches in SemOpenAlex for { <https://semopenalex.org/work/W2114249134> ?p ?o ?g. }
- W2114249134 endingPage "433" @default.
- W2114249134 startingPage "429" @default.
- W2114249134 abstract "The objective of this study was to evaluate the steady-state pharmacokinetics and pharmacodynamics of piperacillin/tazobactam, administered by prolonged infusion, in hospitalised patients requiring antimicrobial therapy. Thirteen patients received 4.5 g every 8 h (q8h), infused over 4 h, and pharmacokinetic parameters were determined by non-compartmental methods. Monte Carlo simulations (10,000 patients) were performed to calculate the cumulative fraction of response (CFR) for seven gram-negative pathogens using minimum inhibitory concentration (MIC) data from the Meropenem Yearly Susceptibility Test Information Collection (2004-2007, USA) as well as the probability of target attainment (PTA) at MICs ranging from 1 microg/mL to 64 microg/mL. The pharmacodynamic target was free piperacillin concentration remaining above the MIC for 50% of the dosing interval. Mean+/-standard deviation maximum and minimum serum concentrations, half-life, volume of distribution at steady-state and systemic clearance of piperacillin were 108.2+/-31.7 microg/mL, 27.6+/-26.3 microg/mL, 2.1+/-1.2 h, 22.1+/-4.0 L and 8.6+/-3.0 L/h, respectively. The CFR was > 90% for Escherichia coli, Serratia marcescens and Citrobacter spp., 88.6% for Enterobacter spp., 87% for Klebsiella pneumoniae, 85.5% for Pseudomonas aeruginosa and 52.8% for Acinetobacter spp. The PTA was 100%, 81.1% and 12.3% at MICs of < or = 16 microg/mL, 32 microg/mL and 64 microg/mL, respectively. Piperacillin/tazobactam 4.5 g q8h infused over 4 h provides excellent target attainment for bacterial pathogens with MICs < or = 16 microg/mL. However, the CFR was < 90% for four of the seven gram-negative pathogens evaluated." @default.
- W2114249134 created "2016-06-24" @default.
- W2114249134 creator A5019978852 @default.
- W2114249134 creator A5049738363 @default.
- W2114249134 creator A5052015278 @default.
- W2114249134 creator A5059327601 @default.
- W2114249134 creator A5062490810 @default.
- W2114249134 creator A5085325136 @default.
- W2114249134 date "2009-11-01" @default.
- W2114249134 modified "2023-10-16" @default.
- W2114249134 title "Steady-state pharmacokinetics and pharmacodynamics of piperacillin/tazobactam administered by prolonged infusion in hospitalised patients" @default.
- W2114249134 cites W1501112436 @default.
- W2114249134 cites W1550111394 @default.
- W2114249134 cites W1967652788 @default.
- W2114249134 cites W1973837711 @default.
- W2114249134 cites W1980701181 @default.
- W2114249134 cites W1988637388 @default.
- W2114249134 cites W1993045657 @default.
- W2114249134 cites W2015984063 @default.
- W2114249134 cites W2036353398 @default.
- W2114249134 cites W2036520108 @default.
- W2114249134 cites W2039118393 @default.
- W2114249134 cites W2047469610 @default.
- W2114249134 cites W2066745723 @default.
- W2114249134 cites W2100510403 @default.
- W2114249134 cites W2105484386 @default.
- W2114249134 cites W2107093554 @default.
- W2114249134 cites W2111882203 @default.
- W2114249134 cites W2112790784 @default.
- W2114249134 cites W2113717321 @default.
- W2114249134 cites W2114671887 @default.
- W2114249134 cites W2131173790 @default.
- W2114249134 cites W2135088547 @default.
- W2114249134 cites W2143024482 @default.
- W2114249134 cites W2146839114 @default.
- W2114249134 cites W2147812473 @default.
- W2114249134 cites W2148505777 @default.
- W2114249134 cites W2149695402 @default.
- W2114249134 cites W2150760368 @default.
- W2114249134 cites W2155512096 @default.
- W2114249134 cites W2164370556 @default.
- W2114249134 cites W2170726356 @default.
- W2114249134 cites W4211194064 @default.
- W2114249134 doi "https://doi.org/10.1016/j.ijantimicag.2009.07.004" @default.
- W2114249134 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19726163" @default.
- W2114249134 hasPublicationYear "2009" @default.
- W2114249134 type Work @default.
- W2114249134 sameAs 2114249134 @default.
- W2114249134 citedByCount "26" @default.
- W2114249134 countsByYear W21142491342012 @default.
- W2114249134 countsByYear W21142491342013 @default.
- W2114249134 countsByYear W21142491342014 @default.
- W2114249134 countsByYear W21142491342015 @default.
- W2114249134 countsByYear W21142491342016 @default.
- W2114249134 countsByYear W21142491342017 @default.
- W2114249134 countsByYear W21142491342018 @default.
- W2114249134 countsByYear W21142491342019 @default.
- W2114249134 countsByYear W21142491342021 @default.
- W2114249134 crossrefType "journal-article" @default.
- W2114249134 hasAuthorship W2114249134A5019978852 @default.
- W2114249134 hasAuthorship W2114249134A5049738363 @default.
- W2114249134 hasAuthorship W2114249134A5052015278 @default.
- W2114249134 hasAuthorship W2114249134A5059327601 @default.
- W2114249134 hasAuthorship W2114249134A5062490810 @default.
- W2114249134 hasAuthorship W2114249134A5085325136 @default.
- W2114249134 hasConcept C104317684 @default.
- W2114249134 hasConcept C111113717 @default.
- W2114249134 hasConcept C112705442 @default.
- W2114249134 hasConcept C126322002 @default.
- W2114249134 hasConcept C139254425 @default.
- W2114249134 hasConcept C176947019 @default.
- W2114249134 hasConcept C185592680 @default.
- W2114249134 hasConcept C2777058267 @default.
- W2114249134 hasConcept C2777637488 @default.
- W2114249134 hasConcept C2777858937 @default.
- W2114249134 hasConcept C2778193466 @default.
- W2114249134 hasConcept C2778266534 @default.
- W2114249134 hasConcept C2778523567 @default.
- W2114249134 hasConcept C2779375183 @default.
- W2114249134 hasConcept C4937899 @default.
- W2114249134 hasConcept C501593827 @default.
- W2114249134 hasConcept C523546767 @default.
- W2114249134 hasConcept C54355233 @default.
- W2114249134 hasConcept C547475151 @default.
- W2114249134 hasConcept C55493867 @default.
- W2114249134 hasConcept C71924100 @default.
- W2114249134 hasConcept C86803240 @default.
- W2114249134 hasConcept C89423630 @default.
- W2114249134 hasConcept C94665300 @default.
- W2114249134 hasConcept C98274493 @default.
- W2114249134 hasConceptScore W2114249134C104317684 @default.
- W2114249134 hasConceptScore W2114249134C111113717 @default.
- W2114249134 hasConceptScore W2114249134C112705442 @default.
- W2114249134 hasConceptScore W2114249134C126322002 @default.
- W2114249134 hasConceptScore W2114249134C139254425 @default.
- W2114249134 hasConceptScore W2114249134C176947019 @default.
- W2114249134 hasConceptScore W2114249134C185592680 @default.
- W2114249134 hasConceptScore W2114249134C2777058267 @default.